Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: HCV Infection
Interventions: Drug: GS-9256; Drug: GS-9190; Drug: Ribavirin
Sponsor: Gilead Sciences
Recruiting - verified March 2010
Condition: Ischemia
Intervention: Drug: ambrisentan
Sponsors: The Cleveland Clinic; Gilead Sciences
Recruiting - verified February 2010